Prognostic value of immune biomarkers in melanoma loco-regional metastases.
The prognosis for patients with melanoma loco-regional metastases is very heterogenous. Adjuvant PD-L1-inhibitors have improved clinical outcome for this patient group, but the prognostic impact of tumour PD-L1 expression and number of tumour infiltrating lymphocytes (TILs) is still largely unknown....
Saved in:
Main Authors: | Emilia Hugdahl, Sura Aziz, Tor A Klingen, Lars A Akslen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2025-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0315284 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biomarkers as Key Contributors in Treating Malignant Melanoma Metastases
by: Camila Ferreira de Souza, et al.
Published: (2012-01-01) -
Prognostic Value of Melanoma Inhibitory Activity Protein in Localized Cutaneous Malignant Melanoma
by: Angela Sandru, et al.
Published: (2014-01-01) -
Outcomes of Treatment for Melanoma Brain Metastases
by: Mantas Janavicius, et al.
Published: (2020-01-01) -
Endoscopic Detection of Gastric Metastases in Skin Melanoma
by: M. Yu. Kabanov, et al.
Published: (2020-12-01) -
Neural recordings can differentiate between spontaneously metastasizing melanomas and melanomas with low metastatic potential.
by: Jay Shiralkar, et al.
Published: (2024-01-01)